Today, a Major Shareholder at Regeneron (NASDAQ: REGN), Sanofi, sold shares of REGN for $42.52M.
Following Sanofi’s last REGN Sell transaction on June 11, 2018, the stock climbed by 83.5%. In addition to Sanofi, 2 other REGN executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Regeneron’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $1.61 billion and quarterly net profit of $551 million. In comparison, last year the company earned revenue of $1.47 billion and had a net profit of $388 million. REGN’s market cap is $42.69B and the company has a P/E ratio of 28.65. Currently, Regeneron has an average volume of 355.7K.
Based on 12 analyst ratings, the analyst consensus is Hold with an average price target of $385.56, reflecting a -2.4% downside.
In the last 30 days, insiders have sold $43.09M worth of REGN shares and purchased $1,062 worth of REGN shares. The insider sentiment on Regeneron has been negative according to 27 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Regeneron Pharmaceuticals, Inc. engages in the discovery, invention, development, manufacture, and commercialization of medicines for the treatment of serious diseases. It products include the following brands: EYLEA, Dupixent, Praluent, Kevzara, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
